Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06050252 |
| Title | Durvalumab With Gemcitabine and Cisplatin for the Treatment of High Risk Resectable Liver Cancer Before Surgery |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| University of Texas MD Anderson Cancer Center LAO | RECRUITING | Houston | Texas | 77030 | United States | Details |
| University of Virginia Cancer Center | RECRUITING | Charlottesville | Virginia | 22908 | United States | Details |